# Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19)

> **NCT05276388** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 1100 (estimated)

## Conditions studied

- Coronavirus Infections

## Interventions

- **OTHER:** biological bank

## Key facts

- **NCT ID:** NCT05276388
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05276388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05276388, "Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05276388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
